Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Nailbiter2on Apr 21, 2024 5:27pm
66 Views
Post# 36000408

RE:RE:RE:RE:RE:So,

RE:RE:RE:RE:RE:So,Can you not just wait
and find out when the rest of us do?
Geeezus!!!

WillHey wrote: I guess you a glass half full guy.  

If they do not have the funds to pay auditors.  Again a cost they knew was coming.

And being halted for not having enough cash to pay for a known cost they have each year is frankly NOT A GOOD THING.

Then how will being able to file Q1 2024 going to make up for it?

Unless you are just stating the obvious?

I assume there will be some sort of delay with the Q1 filings as well though.  If its possible for them to do that is that is what I assume.

At this point i took your comment as "if they can just get these auditors paid they can continue to do quarterly filings on their own not having to pay anyone to do it until next Q4/end of year in which the big worry of if they will have the cash then to do it then or maybe they just want paychecks for the next year at least so just get by this last one"

sorry that last paragraph is a bit wordy and maybe not clear.

To sum it up HOW ARE ANY INVESTORS NOT TOTALLY HOOPED HERE?


<< Previous
Bullboard Posts
Next >>